P2Y 12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials.

Devika AggarwalZainali S ChunawalaZainali S ChunawalaDebabrata MukherjeeDebabrata MukherjeeVardhmaan JainVardhmaan JainSameer AroraThomas A ZelnikerEliano P NavareseGregory J MishkelCheong J LeeSubhash BanerjeeSripal BangaloreJustin P LevisayDeepak L BhattMark J RicciardiArman Qamar

Published in: European heart journal open (2022)

inhibitor monotherapy for secondary prevention is associated with a significant reduction in atherothrombotic events compared with aspirin alone without an increased risk of major bleeding.

Keyphrases

cardiovascular events
coronary artery disease
systematic review
cardiovascular disease
combination therapy
open label
low dose
randomized controlled trial
case control